Proteomic analysis of hippocampal proteins of F344 rats exposed to 1-bromopropane

Toxicology and Applied Pharmacology

Volumn 257, Issue 1, 2011, Pages 93-101

  Huang, Zhenlie ^a,b   Ichihara, Sahoko ^c   Oikawa, Shinji ^d   Chang, Jie ^c   Zhang, Lingyi ^a   Takahashi, Masahide ^a   Subramanian, Kaviarasan ^a   Mohideen, Sahabudeen Sheik ^a   Wang, Yun ^a   Ichihara, Gaku ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Guangdong Prevention and Treatment Center for Occupational Diseases   (China)

^c MIE UNIVERSITY   (Japan)

^d MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

1 Bromopropane; Hippocampus; Mechanism; Neurotoxicity; Proteomics

Indexed keywords

1 BROMOPROPANE; ORGANIC SOLVENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; HIPPOCAMPUS; IMMUNITY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEOMICS; PURINE METABOLISM; RAT; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UBIQUITINATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HIPPOCAMPUS; HYDROCARBONS, BROMINATED; MALE; NERVE TISSUE PROTEINS; PROTEOMICS; RATS; RATS, INBRED F344; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

ANIMALIA; RATTUS;

EID: 81255134304     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.08.023     Document Type: Article

References (64)

1. Akum B.F., Chen M., Gunderson S.I., Riefler G.M., Scerri-Hansen M.M., Firestein B.L. Cypin regulates dendrite patterning in hippocampal neurons by promoting microtubule assembly. Nat. Neurosci. 2004, 7:145-152.
2. Barnsley E.A., Grenby T.H., Young L. Biochemical studies of toxic agents. The metabolism of 1- and 2-bromopropane in rats. Biochem. J. 1966, 100:282-288.
3. B'Hymer C., Cheever K.L. Development of a gas chromatographic test for the quantification of the biomarker 3-bromopropionic acid in human urine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004, 802:361-366.
4. Bischoff F.R., Ponstingl H. Catalysis of guanine nucleotide exchange on Ran by the mitotic regulator RCC1. Nature 1991, 354:80-82.
5. Calabrese V., Scapagnini G., Colombrita C., Ravagna A., Pennisi G., Giuffrida Stella A.M., Galli F., Butterfield D.A. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach. Amino Acids 2003, 25:437-444.
6. Calabrese V., Sultana R., Scapagnini G., Guagliano E., Sapienza M., Bella R., Kanski J., Pennisi G., Mancuso C., Stella A.M., Butterfield D.A. Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease. Antioxid. Redox Signal. 2006, 8:1975-1986.
7. Castro-Caldas M., Neves Carvalho A., Peixeiro I., Rodrigues E., Lechner M.C., Gama M.J. GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum. J. Mol. Neurosci. 2009, 38:114-127.
8. Centers for Disease Control (CDC) Neurologic illness associated with occupational exposure to the solvent 1-bromopropane-New Jersey and Pennsylvania, 2007-2008. MMWR Morb. Mortal. Wkly. Rep. 2008, 57:1300-1302.
9. Ficarro S.B., McCleland M.L., Stukenberg P.T., Burke D.J., Ross M.M., Shabanowitz J., Hunt D.F., White F.M. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol. 2002, 20:301-305.
10. Firestein B.L., Brenman J.E., Aoki C., Sanchez-Perez A.M., EI-Husseini A.E., Bredt D.S. Cypin: a cytosolic regulator of PSD-95 postsynaptic targeting. Neuron 1999, 24:659-672.
11. Fueta Y., Ishidao T., Kasai T., Hori H., Arashidani K. Decreased paired-pulse inhibition in the dentate gyrus of the brain in rats exposed to 1-bromopropane. J. Occup. Health 2000, 42:149-151.
12. 2+/calmodulin-dependent kinase II and mitogen-activated protein kinase in the hippocampus of rats exposed to 1-bromopropane. Life Sci. 2002, 72:521-529.
13. Fueta Y., Ishidao T., Arashidani K., Endo Y., Hori H. Hyperexcitability of the hippocampal CA1 and the dentate gyrus in rats subchronically exposed to a substitute for chlorofluorocarbons, 1-bromopropane vapor. J. Occup. Health 2002, 44:156-165.
14. Fueta Y., Fukuda T., Ishidao T., Hori H. Electrophysiology and immunohistochemistry in the hippocampal CA1 and the dentate gyrus of rats chronically exposed to 1-bromopropane, a substitute for specific chlorofluorocarbons. Neuroscience 2004, 124:593-603.
15. Goldberg M.S., Pisani A., Haburcak M., Vortherms T.A., Kitada T., Costa C., Tong Y., Martella G., Tscherter A., Martins A., Bernardi G., Roth B.L., Pothos E.N., Calabresi P., Shen J. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 2005, 45:489-496.
16. Halogenated Solvents Industry Alliance, Inc.(HSIA) Petition to add n-propyl bromide to list of hazardous air pollutants regulated under section 112 of the Clean Air Act Last accessed April 18, 2011. http://www.hsia.org/news/nPBPetitionsigned.pdf.
17. Harney J., Nemhauser J., Reh C., Trout D., Schrader S. NIOSH Health Hazard Evaluation Report 99-0260-2906 Marx Industries 2003, Sawmills, NC, USA.
18. Herdegen T., Waetzig V. AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene 2001, 20:2424-2437.
19. Ichihara G., Asaeda N., Kumazawa T., Tagawa Y., Kamijima M., Yu X., Kondo H., Nakajima T., Kitoh J., Yu H., Moon Y.H., Hisanaga N., Takeuchi Y. Testicular and hematopoietic toxicity of 2-bromopropane, a substitute for ozone layer-depleting chlorofluorocarbons. J. Occup. Health 1997, 39:57-63.
20. Ichihara G., Kitoh J., Yu X., Asaeda N., Iwai H., Kumazawa T., Shibata E., Yamada T., Wang H., Xie Z., Takeuchi Y. 1-Bromopropane, an alternative to ozone layer depleting solvents, is dose-dependently neurotoxic to rats in long-term inhalation exposure. Toxicol. Sci. 2000, 55:116-123.
21. Ichihara G., Miller J.K., Ziolkowska A., Itohara S., Takeuchi Y. Neurological disorders in three workers exposed to 1-bromopropane. J. Occup. Health 2002, 44:1-7.
22. Ichihara G., Li W., Ding X., Peng S., Yu X., Shibata E., Yamada T., Wang H., Itohara S., Kanno S., Sakai K., Ito H., Kanefusa K., Takeuchi Y. A survey on exposure level, health status, and biomarkers in workers exposed to 1-bromopropane. Am. J. Ind. Med. 2004, 45:63-75.
23. Ichihara G., Li W., Shibata E., Ding X., Wang H., Liang Y., Peng S., Itohara S., Kamijima M., Fan Q., Zhang Y., Zhong E., Wu X., Valentine W.M., Takeuchi Y. Neurologic abnormalities in workers of a 1-bromopropane factory. Environ. Health Perspect. 2004, 112:1319-1325.
24. Ichihara, G., Kitoh, J., Li, W., Ding, X., Ichihara S., Takeuchi Y., in press Neurotoxicity of 1-bromopropane: Evidence from animal experiments and human studies. J. Advanced Res. doi:. http://doi:10.1016/j.jare.2011.04.005.
25. Jones A.R., Walsh D.A. The oxidative metabolism of 1-bromopropane in the rat. Xenobiotica 1979, 9:763-772.
26. Kadowaki T., Goldfarb D., Spitz L.M., Tartakoff A.M., Ohno M. Regulation of RNA processing and transport by a nuclear guanine nucleotide release protein and members of the Ras superfamily. EMBO J. 1993, 12:2929-2937.
27. Kahle P.J., Waak J., Gasser T. DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders. Free Radical Biol. Med. 2009, 47:1354-1361.
28. Khan S., O'Brien P.J. 1-bromoalkanes as new potent nontoxic glutathione depletors in isolated rat hepatocytes. Biochem. Biophys. Res. Commun. 1991, 179:436-441.
29. Kim R.H., Smith P.D., Aleyasin H., Hayley S., Mount M.P., Pownall S., Wakeham A., You-Ten A.J., Kalia S.K., Horne P., Westaway D., Lozano A.M., Anisman H., Park D.S., Mak T.W. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc. Natl. Acad. Sci. U S A 2005, 102:5215-5220.
30. Kim H.E., Jiang X., Du F., Wang X. PHAPI, CAS, and Hsp70 promote apoptosome formation by preventing Apaf-1 aggregation and enhancing nucleotide exchange on Apaf-1. Mol. Cell 2008, 30:239-247.
31. Kim M.S., Park H.R., Park M., Kim S.J., Kwon M., Yu B.P., Chung H.Y., Kim H.S., Kwack S.J., Kang T.S., Kim S.H., Lee J. Neurotoxic effect of 2,5-hexanedione on neural progenitor cells and hippocampal neurogenesis. Toxicology 2009, 260:97-103.
32. Kisby G.E., Standley M., Park T., Olivas A., Fei S., Jacob T., Reddy A., Lu X., Pattee P., Nagalla S.R. Proteomic analysis of the genotoxicant methylazoxymethanol (MAM)-induced changes in the developing cerebellum. J. Proteome Res. 2006, 5:2656-2665.
33. Li W., Shibata E., Zhou Z., Ichihara S., Wang H., Wang Q., Li J., Zhang L., Wakai K., Takeuchi Y., Ding X., Ichihara G. Dose-dependent neurologic abnormalities in workers exposed to 1-bromopropane. J. Occup. Environ. Med. 2010, 52:769-777.
34. LoPachin R.M., Jones R.C., Patterson T.A., Slikker W., Barber D.S. Application of proteomics to the study of molecular mechanisms in neurotoxicology. Neurotoxicology 2003, 24:761-775.
35. Majersik J.J., Caravati E.M., Steffens J.D. Severe neurotoxicity associated with exposure to the solvent 1-bromopropane (n-propyl bromide). Clin. Toxicol. (Phila) 2007, 45:270-276.
36. Martin B., Brenneman R., Becker K.G., Gucek M., Cole R.N., Maudsley S. iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the interface between physiology and disease. PLoS One 2008, 3:e2750.
37. Matsumoto T., Beach D. Premature initiation of mitosis in yeast lacking RCC1 or an interacting GTPase. Cell 1991, 66:347-360.
38. Matsumoto T., Beach D. Interaction of the piml/spil mitotic checkpoint with a protein phosphatase. Mol. Biol. Cell 1993, 4:337-345.
39. Mohideen S.S., Ichihara S., Banu S., Liu F., Kitoh J., Ichihara G. Changes in neurotransmitter receptor expression levels in rat brain after 4-week exposure to 1-bromopropane. Neurotoxicology 2009, 30:1078-1083.
40. Mohideen S.S., Ichihara G., Ichihara S., Nakamura S. Exposure to 1-bromopropane causes degeneration of noradrenergic axons in the rat brain. Toxicology 2011, 285:67-71.
41. Moore M.S., Blobel G. The GTP-binding protein Ran/TC4 is required for protein import into the nucleus. Nature 1993, 365:661-663.
42. Oikawa S., Yamada T., Minohata T., Kobayashi H., Furukawa A., Tada-Oikawa S., Hiraku Y., Murata M., Kikuchi M., Yamashima T. Proteomic identification of carbonylated proteins in the monkey hippocampus after ischemia-reperfusion. Free Radic. Biol. Med. 2009, 46:1472-1477.
43. Park H.R., Kim M.S., Kim S.J., Park M., Kong K.H., Kim H.S., Kwack S.J., Kang T.S., Kim S.H., Kim H.S., Lee J. Acrylamide induces cell death in neural progenitor cells and impairs hippocampal neurogenesis. Toxicol. Lett. 2010, 193:86-93.
44. Pham D.N., Luo H., Wu J. Reduced Ran expression in Ran (+/-) fibroblasts increases cytokine-stimulated nuclear abundance of the AP-1 subunits c-Fos and c-Jun. FEBS Lett. 2010, 584:4623-4626.
45. Qiao X., Pham D.N., Luo H., Wu J. Ran overexpression leads to diminished T cell responses and selectively modulates nuclear levels of c-Jun and c-Fos. J. Biol. Chem. 2010, 285:5488-5496.
46. Raymond L.W., Ford M.D. Severe illness in furniture makers using a new glue: 1-bromopropane toxicity confounded by arsenic. J. Occup. Environ. Med. 2007, 49:1009-1019.
47. Reh C.M., Mortimer V.D., Nemhauser J.B., Trout D. NIOSH Health Hazard Evaluation Report 98-0153-2883 2002, Custom Products, Mooresville, NC, USA.
48. Ryabinin A.E. Role of hippocampus in alcohol-induced memory impairment: implications from behavioral and immediate early gene studies. Psychopharmacology (Berl) 1998, 139:34-43.
49. Sazer S., Nurse P. A fission yeast RCC1-related protein is required for the mitosis to interphase transition. EMBO J. 1994, 13:606-615.
50. Schonberger S.J., Edgar P.F., Kydd R., Faull R.L., Cooper G.J. Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics 2001, 1:1519-1528.
51. Sclar G. Encephalomyeloradiculoneuropathy following exposure to an industrial solvent. Clin. Neurol. Neurosurg. 1999, 101:199-202.
52. Takeuchi Y., Huang J., Shibata E., Hisanaga N., Ono Y. A trial to automatize an organic solvent exposure system for small animals. Jpn. J. Ind. Health 1989, 31:722.
53. Tchaikovskaya T., Fraifeld V., Urphanishvili T., Andorfer J.H., Davies P., Listowsky I. Glutathione S-transferase hGSTM3 and ageing-associated neurodegeneration: relationship to Alzheimer's disease. Mech. Ageing Dev. 2005, 126:309-315.
54. The Human Protein Atlas Version 8.0 updated 2011-02-16 http://www.proteinatlas.org.
55. Thomas P.D., Campbell M.J., Kejariwal A., Mi H., Karlak B., Daverman R., Diemer K., Muruganujan A., Narechania A. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 2003, 13:2129-2141.
56. U.S.Environmental Protection Agency (USEPA) Protection of stratospheric ozone: listing of substitutes for ozone depleting substances. Request for data and advanced notice of proposed rulemaking. 40 CFR Part 82. Fed. Regist. 1999, 64:8043-8048.
57. U.S.Environmental Protection Agency (USEPA) Protection of stratospheric ozone: notice 14 for significant new alternatives policy program. 40 CFR Part 82. Fed. Regist. 2000, 65:78977-78989.
58. Ueno S., Yoshida Y., Fueta Y., Ishidao T., Liu J., Kunugita N., Yanagihara N., Hori H. Changes in the function of the inhibitory neurotransmitter system in the rat brain following subchronic inhalation exposure to 1-bromopropane. Neurotoxicology 2007, 28:415-420.
59. Wang H., Ichihara G., Ito H., Kato K., Kitoh J., Yamada T., Yu X., Tsuboi S., Moriyama Y., Sakatani R., Shibata E., Kamijima M., Itohara S., Takeuchi Y. Biochemical changes in the central nervous system of rats exposed to 1-bromopropane for seven days. Toxicol. Sci. 2002, 67:114-120.
60. Wang H., Ichihara G., Ito H., Kato K., Kitoh J., Yamada T., Yu X., Tsuboi S., Moriyama Y., Takeuchi Y. Dose-dependent biochemical changes in rat central nervous system after 12-week exposure to bromopropane. Neurotoxicology 2003, 24:199-206.
61. Yoshida Y., Liu J.Q., Nakano Y., Ueno S., Ohmori S., Fueta Y., Ishidao T., Kunugita N., Yamashita U., Hori H. 1-BP inhibits NF-κB activity and Bcl-xL expression in astrocytes in vitro and reduces Bcl-xL expression in the brains of rats in vivo. Neurotoxicology 2007, 28:381-386.
62. Yu X., Ichihara G., Kitoh J., Xie Z., Shibata E., Kamijima M., Asaeda N., Takeuchi Y. Preliminary report on the neurotoxicity of 1-bromopropane, an alternative solvent for chlorofluorocarbons. J. Occup. Health 1998, 40:234-235.
63. Yu X., Ichihara G., Kitoh J., Xie Z., Shibata E., Kamijima M., Takeuchi Y. Neurotoxicity of 2-bromopropane and 1-bromopropane, alternative solvents for chlorofluorocarbons. Environ. Res. 2001, 85:48-52.
64. Yu Z., Luo H., Fu W., Mattson M.P. The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of calcium homeostasis. Exp. Neurol. 1999, 155:302-314.